U.K. drugmaker is in talks with the FDA to supply estrogen patches to the U.S.
Get Quartz in your inbox
Free daily briefing on global business news.
U.K. drugmaker is in talks with the FDA to supply estrogen patches to the U.S.
The company has expanded manufacturing as U.S. prescriptions containing estradiol, a form of estrogen, doubled in two years
Anadolu / Getty Images
Theramex, a London-based drugmaker, is in talks with the U.S. Food and Drug Administration about selling its estrogen patches in the U.S., CEO Robert Stewart told Bloomberg.
Theramex has scaled up production because it anticipates the FDA could let the sales proceed, Stewart said.
"We've been in dialogue with the FDA," Stewart said, according to Bloomberg. "They have the information that they would need to be able to issue a special import, and if they do, we'd be able to immediately respond."
Theramex has no approved products in the U.S., according to Bloomberg. In exceptional cases, the........
